A detailed history of Shell Asset Management CO transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 1,435 shares of MEDP stock, worth $577,444. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,435
Previous 1,497 4.14%
Holding current value
$577,444
Previous $459,000 26.36%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $17,661 - $25,625
-62 Reduced 4.14%
1,435 $580,000
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $102,611 - $141,018
-451 Reduced 23.15%
1,497 $459,000
Q3 2023

Nov 08, 2023

SELL
$233.98 - $281.67 $7,955 - $9,576
-34 Reduced 1.72%
1,948 $472,000
Q2 2023

Jul 28, 2023

SELL
$187.26 - $240.17 $2,059 - $2,641
-11 Reduced 0.55%
1,982 $476,000
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $1,220 - $1,676
-7 Reduced 0.35%
1,993 $375,000
Q4 2022

Feb 07, 2023

SELL
$153.06 - $226.57 $62,142 - $91,987
-406 Reduced 16.87%
2,000 $425,000
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $23,365 - $29,380
161 Added 7.17%
2,406 $378,000
Q2 2022

Aug 09, 2022

BUY
$130.2 - $168.03 $76,297 - $98,465
586 Added 35.32%
2,245 $336,000
Q1 2022

May 04, 2022

SELL
$138.87 - $214.31 $34,162 - $52,720
-246 Reduced 12.91%
1,659 $271,000
Q4 2021

Feb 09, 2022

BUY
$182.74 - $227.9 $89,177 - $111,215
488 Added 34.44%
1,905 $415,000
Q3 2021

Nov 04, 2021

SELL
$170.18 - $198.21 $10,210 - $11,892
-60 Reduced 4.06%
1,417 $268,000
Q2 2021

Aug 12, 2021

BUY
$158.62 - $194.3 $12,689 - $15,544
80 Added 5.73%
1,477 $261,000
Q1 2021

May 10, 2021

BUY
$132.02 - $168.26 $184,431 - $235,059
1,397 New
1,397 $229,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.